Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-12-04
1997-04-01
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540586, 514812, A61K 31395
Patent
active
056165757
ABSTRACT:
Ibogaine analogs are provided, which are phenyl-substituted-hexahydroazepino[4,5-b]indoles useful to treat cocaine addiction and the use of other addictive substances.
REFERENCES:
patent: 3714193 (1973-01-01), Suh
patent: 4499096 (1985-02-01), Lotsof
patent: 4938949 (1990-07-01), Borch et al.
patent: 5006521 (1991-09-01), Lafferty et al.
patent: 5035878 (1991-07-01), Borch et al.
patent: 5258378 (1993-11-01), Clark et al.
S.L.T. Cappendijk et al., "Inhibitory Effects of Ibogaine on Cocaine Self-Administration in Rats," Eur. J. Pharmacol., 241, 261-265 (1993).
D.C. Deecher et al., "Mechanisms of Action of Ibogaine and Harmaline Congeners Based on Radioligand Binding Studies," Brain Res., 571, 242-247 (1992).
G. Di Chiara et al., "Drugs Abused by Humans Preferentially Increase Synaptic Dopamine Concentrations in the Mesolimbic System of Freely Moving Rats," Proc. Natl. Acad. Sci., 85, 5274-5278 (1988).
A.J. Elliot et al., "Synthesis of Some 5-Phenylhexahydroazepino[4,5-b] indoles as Potential neuroleptic Agents," J. Med. Chem., 23, 1268-1269 (1980).
D.M. Gallant et al., "A Controlled Evaluation in Chronic Schizophrenic Patients," Current Therapeutic Res., 9, 579-580 (1967).
S.D. Glick et al., "Local Effects of Ibogaine on Extracellular Levels of Dopamine and its Metabolites in Nucleus Accumbens and Striatum: Interactions with D-Amphetamine," Brain Res., 628, 201-208 (1993).
J.B. Hester et al., "Azepinoindoles. I. Hexahydroazepinol [4, 5-b] indoles," J. Med. Chem., 11, 101-106 (1968).
G.F. Koob et al., "Neuroanatomical Substrates of Drug Self-Administration," The Neuropharmacological Basis of Reward, Clarendon 214-263 (1989).
E. O'Hearn et al., "Degeneration of Purkinje Cells in Parasagittal Zones of the Cerebellar Vermis after Treatment with Ibogaine or Harmaline," Neurosci., 55, 303-310 (1993).
E. O'Hearn et al., "Ibogaine Induces Glial Activation in Parasagittal Zones of the Cerebellum," Neuroreport., 4, 299-302 (1993).
J.A. Schneider et al., "Neuropharmacological Studies on Ibogaine, an Indole Alkaloid with Central Stimulant Properties," Ann. NY Acad. Sci., 66, 765-776 (1957).
H. Sershen et al., "Ibogaine Reduces Preference for Cocaine Consumption in C57BL/6By Mice," Pharmacol. Biochem. Behav., 47, 13-19 (1994).
G. Singbartl et al., "Structure-Activity Relationships of Intracerebrally Injected Tremorigenic Indole Alkaloids," Neuropharmacology, 12, 239-244 (1973).
W.L. Woolverton et al., "Neurobiology of Cocaine Abuse," Trends Pharmacol. Sci., 13, 193-200 (1992).
G. Zetler et al., "Cerebral Pharmacokinetics of Tremor-Producing Harmala and Iboga Alkaloids," Pharmacology, 7, 237-248 (1972).
Efange S. Mbua N.
Mash Deborah C.
Reamer James H.
Regents of the University of Minnesota
University of Miami
LandOfFree
Bioactive tricyclic ibogaine analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioactive tricyclic ibogaine analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactive tricyclic ibogaine analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-538999